New dopaminergic agonists

被引：0

作者：

De Mattos, JP ^{[1
]}

Mattos, VMDC ^{[1
]}

机构：

[1] Univ Fed Rio de Janeiro, Serv Neurol, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 1999年 / 57卷 / 2A期

关键词：

levodopa; dopaminergic agonists; Parkinson's disease;

D O I：

10.1590/S0004-282X1999000200029

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

We present a brief review of the literature about dopaminergic a,agonists. We report the five known dopaminergic receptors, where they are located, the advantages and disadvantages of the employment in parkinsonian patients. The dopaminergic agonists were introduced to control the limitations of levodopa-increasing the therapheutic window. We analyse the pharmacocynetic efficacy and the side effects of cabergoline, ropinirole and pramipexole.

引用

页码：329 / 332

页数：4

共 50 条

[1] Design and Synthesis of Dopaminergic Agonists
Soledad Matute, Maria
Matute, Rosa
Merino, Pedro
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (25) : 2790 - 2825
[2] An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson's disease
Scanga, Amanda
Lafontaine, Anne -Louise
Kaminska, Marta
JOURNAL OF CLINICAL SLEEP MEDICINE, 2023, 19 (06): : 1133 - 1144
[3] Historical context of dopaminergic agonists
Estrada-Bellmann, Ingrid
Camara-Lemarroy, Carlos
Delgado-Garcia, Guillermo
Cerda-Contreras, Christopher
REVISTA MEXICANA DE NEUROCIENCIA, 2018, 19 (03): : 74 - 84
[4] Dopaminergic agonists in Parkinson's disease
Alonso Canovas, A.
Luquin Piudo, R.
Garcia Ruiz-Espiga, P.
Burguera, J. A.
Campos Arillo, V.
Castro, A.
Linazasoro, G.
Lopez del Val, J.
Vela, L.
Martinez Castrillo, J. C.
NEUROLOGIA, 2014, 29 (04): : 230 - 241
[5] A SIMPLE BIOLOGICAL WAY TO SCREEN DOPAMINERGIC AGONISTS
DEAZEREDO, FAM
RIBEIRO, MF
METABOLIC BRAIN DISEASE, 1992, 7 (04) : 211 - 221
[6] The role of dopaminergic agonists in congestive heart failure
Semeraro, C
Marchini, F
Ferlenga, P
Masotto, C
Morazzoni, G
Pradella, L
Pocchiari, F
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (1-2) : 201 - 215
[7] Receptor-binding and pharmacokinetic properties of dopaminergic agonists
Kvernmo, Trond
Houben, John
Sylte, Ingebrigt
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (12) : 1049 - 1067
[8] Continuous dopaminergic stimulation and novel formulations of dopamine agonists
Stocchi, Fabrizio
JOURNAL OF NEUROLOGY, 2011, 258 : S316 - S322
[9] Continuous dopaminergic stimulation and novel formulations of dopamine agonists
Fabrizio Stocchi
Journal of Neurology, 2011, 258 : 316 - 322
[10] New dopaminergic therapies for PD motor complications
Larson, Danielle
Simuni, Tanya
NEUROPHARMACOLOGY, 2022, 204

← 1 2 3 4 5 →